Bevazza 400 mg Injection
  1. Home
  2. Pharma Products
  3. Lupin Ltd
  4. Bevazza 400 mg Injection

Bevazza 400 mg Injection

Bevazza 400 mg Injection contains bevacizumab 400 mg, a monoclonal antibody used in cancer treatment. It is used for cancers including colorectal, non-small-cell lung, kidney, ovarian, cervical, and certain other cancers. The medicine is given as an intravenous infusion by a healthcare professional under medical supervision.

BUY NOW

Category

Bevacizumab works by blocking vascular endothelial growth factor (VEGF), which helps reduce the formation of new blood vessels that supply tumors. It is commonly used together with other anticancer medicines according to the specific cancer and treatment protocol. Blood pressure, urine protein, bleeding risk, and wound healing may need monitoring during treatment. The dose and treatment schedule are individualized by the oncologist based on the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg
Concentration 25 mg/mL
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial, 16 mL

Product Also Known As

Bevazza 400 mg Injection, Bevazza 400mg Injection, Bevazza 400 mg Vial, Bevazza 400mg Vial, Bevacizumab 400 mg Injection, Bevacizumab 400mg Injection, Bevacizumab 400 mg Vial